Navigation Links
folding in Biological Technology

Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements

... chaperone," noted John Crowley. Other Protein folding and Stabilization Programs: In 2008, Amicus ... diseases that could benefit from improved protein folding and stabilization. The company's advanced ... in cells, leading to improved protein folding and trafficking, and increased activity. Amicus ...

Bioinformatics Expert Dr. Jiaan Yang Joins Sundia MediTech With Innovative PFSC Technology

... in Shanghai, China announced today that Sundia has acquired Protein folding Shape Code (PFSC) technology for doing probe binding site for drug ... applied mathematics on this biology subject, generated a set of Protein folding Shape Code (PFSC) for a complete description of protein's complex 3D ...

First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes

... paper titled, Monitoring Copopulated Conformational States During Protein folding Events Using Electrospray Ionization-Ion Mobility Spectrometry-Mass ... is: Monitoring co-populated conformational states during protein folding events using ESI -IMS-MS, D. P. Smith, K. Giles, R. H. Bateman, S. E. ...

BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco

... Target Underlying Defect in Cystic Fibrosis; CFTR folding and Transport NOVATO, Calif., Aug. 22 /PRNewswire-FirstCall/ -- ... and have demonstrated a high degree of potency and specificity for the folding and activation of the abnormal CFTR protein. We look forward to ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies

... and therapeutics. OMP™ (Oligonucleotide Modeling Platform™), the core engine that runs all of DNA Software's tools, models in silico the folding and hybridization of nucleic acids with exception accuracy. Visual OMP™ is a platform program for the design, simulation, and analysis of ...

Canadian researchers discover gene related to the appearance of aging

... health benefits. However, proline is not completely understood. Researchers know that it helps make 'kinks' in protein chains, critical for correct folding of these proteins. But it seems to play an independent role in protection from cellular stress. Proline made internally in our bodies may have a ...

Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

DNA Software, Inc. Honored as One of the 2009 "Michigan 50 Companies to Watch"

... and therapeutics. OMP™ (Oligonucleotide Modeling Platform™), the core engine that runs all of DNA Software's tools, models in silico the folding and hybridization of nucleic acids with exception accuracy. Visual OMP™ is a platform program for the design, simulation, and analysis of ...

Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Change to Board of Directors

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Could Database Software Help Cure Alzheimer's and Save the Earth?

... Parkinson's disease, emphysema and cystic fibrosis. Because experimental approaches provide only limited amounts of information about the actual folding process, Daggett Research Group employs computer simulations, which generate massive amounts of data that must be analyzed. The lab has already ...

Amicus Therapeutics Announces Third Quarter 2008 Financial Results

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Third Quarter 2008 Results Release Date

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Opens Research Facility in San Diego

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Second Quarter 2008 Results Release Date

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Boys in the Hood

... You Need table, heading their list was an emergency escape hood worthy of James Bond: a one size fits all concealable hood weighing under a pound, folding to the dimensions of a DVD case, and donnable in ten seconds. Furthermore, the hood must be maintenance-free, filter nerve, blood, and blister ...

Cystic Fibrosis - Axentis Pharma Takes Over Patents and Continues Development of Innovative Platform Technology

... Swiss biotechnology company. The company is using a patent-pending platform technology to develop therapies for diseases caused by incorrect protein folding in the endoplasmic reticulum. The most prominent example of such diseases is cystic fibrosis (mucoviscidosis). The company is in final preparation to ...

Studies Show USGI Medical's EndoSurgical Operating System(TM) Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass

... precision and control; allows the use of multiple, robust instruments for two-handed operation and enables rapid, durable suturing for tissue folding and wound closure. About USGI Medical USGI Medical is the leader in Incisionless Surgery. USGI's EndoSurgical Operating System(TM) (EOS) provides ...

Amarin Announces Completion of the First Tranche of $60 Million Private Placement

... 1995. Dr. Gordon received a Ph.D. in Molecular Biology from the Massachusetts Institute of Technology. His doctoral work involved studies of protein folding and assembly. He received a Bachelors degree from Harvard College. Dr. Eric Aguiar is a Partner at Thomas, McNerney & Partners. He has 16 years of ...

Amicus Therapeutics Announces First Quarter 2008 Financial Results

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Boys in the Hood

... You Need table, heading their list was an emergency escape hood worthy of James Bond: a one size fits all concealable hood weighing under a pound, folding to the dimensions of a DVD case, and donnable in ten seconds. Furthermore, the hood must be maintenance-free, filter nerve, blood, and blister ...

Foldable and stretchable, silicon circuits conform to many shapes

... circuit that can wrap around complex shapes such as spheres, body parts and aircraft wings, and can operate during stretching, compressing, folding and other types of extreme mechanical deformations, without a reduction in electrical performance. The notion that silicon cannot be used in such ...

Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women

... said Kari Stefansson, CEO of deCODE. "We are also excited that we can now immediately enable individuals to see if they carry such variants, by folding the findings announced today -- and others we expect to publish in the near future -- into our deCODEme(TM) personal genome analysis service." The ...

Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Host R&D Day

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...
Other Contents
(Date:7/11/2014)... report from the Wildlife Conservation Society shows that ... economically valuable species such as lobster, conch, and ... re-colonize nearby reef areas. , The reporttitled "Review ... review of research literature from no-take areas around ... Craig Dahlgren, a recognized expert in marine protected ...
(Date:7/11/2014)... Chicago is creating a new professorship in tissue ... Institute for Molecular Engineering and the Marine Biological ... the Millicent and Eugene Bell Foundation., The Eugene ... the Institute for Molecular Engineering. That endowed chair ... the MBL,s Eugene Bell Center for Regenerative Biology ...
(Date:7/11/2014)... 2014, Shenzhen, China Researchers from Salk Institute for ... first time evaluated the safety and reliability of ... developed a new method, TALEN-HDAdV, which could significantly ... cell (hiPSC). This study published online in ... foundation for stem cell-based gene therapy. , The ...
Breaking Biology News(10 mins):Belize's lobster, conch, and fish populations rebuild in no-take zones 2New professorship in tissue engineering links molecular engineering, marine biology 2A new genome editing method brings the possibility of gene therapies closer to reality 2
(Date:7/13/2014)... treatment and variations in the quality of care are ... patients still varies widely between regions within Europe, according ... adults to date, published in The Lancet Oncology ... for most cancers of the blood has increased over ... of new targeted drugs in the early 2000s such ...
(Date:7/13/2014)... type-1 diabetes could improve patient care worldwide and ... the device,s inventors at the Stanford University School ... be published online July 13 in Nature ... type-1 diabetes outside hospital settings. The handheld microchips ... mellitus, which are both characterized by high blood-sugar ...
(Date:7/13/2014)... irrigation systems are mainly utilized for agriculture in order ... maintain soil quality. The application of micro irrigation systems ... generator for manufacturers in future. The trend of utilizing ... to the adoption of micro irrigation techniques for agriculture, ... for micro irrigation systems, as they reduce the overall ...
(Date:7/13/2014)... MarketsandMarkets recently conducted a study on the ... rendering; Layout and Animation; Image Reconstruction]: Global Advancements, ... analyzes and studies the major market drivers, restraints, ... Europe, Middle East and Africa, Asia-Pacific and Latin ... of the 3D imaging market, providing an in-depth ...
(Date:7/13/2014)... The federal court overseeing thousands of ... against Johnson & Johnson’s Ethicon, Inc. is preparing to ... to get underway next month. According to an Amended ... Southern District of West Virginia on July 9, 2014, ... 2014 at 3:00 p.m. July selection is slated to ...
Breaking Medicine News(10 mins):Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 3Health News:Stanford researchers invent nanotech microchip to diagnose type-1 diabetes 2Health News:Stanford researchers invent nanotech microchip to diagnose type-1 diabetes 3Health News:Stanford researchers invent nanotech microchip to diagnose type-1 diabetes 4Health News:Agricultural Micro Irrigation System Market is Expected to Grow at a CAGR of 18.1%, from 2013 to 2018 - New Report by MicroMarket Monitor 2Health News:Agricultural Micro Irrigation System Market is Expected to Grow at a CAGR of 18.1%, from 2013 to 2018 - New Report by MicroMarket Monitor 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4
Other TagsOther Tags